The novel coronavirus disease 2019 (COVID-19) was characterised as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the healthcare market, a major part of the pharmaceutical sector. There are already considerable impacts, both in the short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden.
Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharmaceutical production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels.
In this special live broadcast, we will be interviewing industry professionals and discussing the ongoing developments as well as impending changes and challenges faced by this industry sector.